Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 457

1.

Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.

Rizza RA, Haymond MW, Verdonk CA, Mandarino LJ, Miles JM, Service FJ, Gerich JE.

Diabetes. 1981 May;30(5):377-81.

PMID:
6262168
2.
3.

Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients.

Del Prato S, Riccio A, Vigili de Kreutzenberg S, Dorella M, Avogaro A, Marescotti MC, Tiengo A.

Metabolism. 1993 Jan;42(1):24-9.

PMID:
8446044
4.

Glucose turnover in insulinoma--a case report.

Hanna AK, Vranic M, Zinman B.

Diabetes Res Clin Pract. 1987 Mar-Apr;3(2):111-4.

PMID:
3032548
5.

Effect of ketone bodies on glucose production and utilization in the miniature pig.

Müller MJ, Paschen U, Seitz HJ.

J Clin Invest. 1984 Jul;74(1):249-61.

6.

Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action.

Vigili de Kreutzenberg S, Riccio A, Dorella M, Avogaro A, Marescotti MC, Tiengo A, del Prato S.

Eur J Clin Invest. 1995 May;25(5):360-7.

PMID:
7628524
7.

C-peptide suppression test for insulinoma.

Service FJ, Horwitz DL, Rubenstein AH, Kuzuya H, Mako ME, Reynolds C, Molnar GD.

J Lab Clin Med. 1977 Jul;90(1):180-6.

PMID:
194989
8.

Metabolic profiles in patients with insulinoma.

Hale PJ, Nattrass M.

Clin Endocrinol (Oxf). 1989 Jan;30(1):29-38.

PMID:
2550166
10.

Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans.

De Feo P, Perriello G, De Cosmo S, Ventura MM, Campbell PJ, Brunetti P, Gerich JE, Bolli GB.

Diabetes. 1986 May;35(5):563-9.

PMID:
2869997
11.

Plasma insulin response to various secretagogues in insulinoma.

Ohneda A, Kobayashi T, Nihei J.

Tohoku J Exp Med. 1982 Apr;136(4):447-57.

12.

The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.

Hoff AO, Vassilopoulou-Sellin R.

Cancer. 1998 Apr 15;82(8):1585-92.

PMID:
9554538
13.

Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.

Tse TF, Clutter WE, Shah SD, Miller JP, Cryer PE.

J Clin Invest. 1983 Jul;72(1):270-7.

14.

Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.

Gin H, Brottier E, Dupuy B, Guillaume D, Ponzo J, Aubertin J.

Arch Intern Med. 1987 May;147(5):985-7.

PMID:
3034180
15.

Insulinoma with normal plasma insulin concentrations and insulin/glucose ratios during hypoglycemic episodes.

Hattori N, Ishihara T, Saiki Y, Moridera K, Hino M, Ikekubo K, Kurahachi H.

Intern Med. 1994 Dec;33(12):813-6.

16.

Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma.

Battezzati A, Terruzzi I, Perseghin G, Bianchi E, Di Carlo V, Pozza G, Luzi L.

Diabetes. 1995 Jul;44(7):837-44.

PMID:
7789652
17.

Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.

Igawa K, Mugavero M, Shiota M, Neal DW, Cherrington AD.

Diabetes. 2002 Oct;51(10):3033-42.

18.

Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.

Nauck M, Stöckmann F, Creutzfeldt W.

Eur J Clin Invest. 1990 Feb;20(1):15-28.

PMID:
1969348
20.

Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).

Stehouwer CD, Lems WF, Fischer HR, Hackeng WH, Naafs MA.

Acta Endocrinol (Copenh). 1989 Jul;121(1):34-40.

PMID:
2545062

Supplemental Content

Support Center